propidium has been researched along with rosiglitazone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bugelski, P; Elcock, F; Hahn, L; Hart, T; McFarland, D; Morgan, DG; Narayanan, PK; Schwartz, L; Zhang, C | 1 |
| Dai, B; Fu, L; Jia, J; Li, L; Liu, J; Mei, C; Shen, J; Tang, J; Wang, L; Xiong, X; Ye, Y | 1 |
2 other study(ies) available for propidium and rosiglitazone
| Article | Year |
|---|---|
Troglitazone-induced intracellular oxidative stress in rat hepatoma cells: a flow cytometric assessment.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Membrane; Chromans; Coloring Agents; Dose-Response Relationship, Drug; Fibrinolytic Agents; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Glutathione; Membrane Potentials; Mitochondria; Models, Chemical; Oxidative Stress; Oxygen; Phenanthridines; Propidium; Rats; Rosiglitazone; Superoxides; Thiazolidinediones; Troglitazone | 2003 |
Antitumor activity of a novel series of alpha-aryloxy-alpha-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell lines.
Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; L-Lactate Dehydrogenase; Phenylpropionates; PPAR gamma; Propidium; Rosiglitazone; Thiazolidinediones | 2009 |